SA
DMRA logo
Damora Therapeutics, Inc.(DMRA)
Closing price · checked 8:21 PM ETAbout this dataData status
$23.22▼-1.08 (-4.44%)
Extended:$23.22+0.00 (+0.00%)· 8:21 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Damora Therapeutics, Inc. (DMRA)

Stock-Based Compensation

$8.02M

TTM · Period ending: · USD

DMRA logo

DMRA Stock-Based Compensation

Latest reported$8.02M
DMRA Stock-Based Comp ($0.00 → $8.02M)
Powered by
High-resolution chart · PNG

What is stock-based compensation?

Non-cash compensation expense paid in equity.

DMRA stock-based compensation history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Damora Therapeutics, Inc. Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)Change
998,000—
0—
0—
0—
0—
0—
0—
0—

Frequently asked questions: DMRA stock-based compensation

What is Damora Therapeutics, Inc. (DMRA)'s current stock-based compensation?

Damora Therapeutics, Inc. (DMRA)'s latest reported stock-based compensation (TTM) is $8.02M as of Sep 30, 2026. Non-cash compensation expense paid in equity.

How much historical stock-based compensation data is available for DMRA?

Stock Alarm Pro provides 8 dated annual fiscal periods observations for Damora Therapeutics, Inc. (DMRA)'s stock-based compensation, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare DMRA's stock-based compensation to peers or set an alert?

You can open DMRA's stock-based compensation in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on DMRA delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.